These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

80 related items for PubMed ID: 1896092

  • 1. Oral administration of 24,25(OH)2D3 suppresses the serum parathyroid hormone levels of dialysis patients.
    Ben-Ezer D, Shany S, Conforty A, Rapoport J, Edelstein S, Bdolah-Abram T, Kafka DR, Chaimovitz C.
    Nephron; 1991; 58(3):283-7. PubMed ID: 1896092
    [Abstract] [Full Text] [Related]

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 3. 24,25-dihydroxy vitamin D3 treatment inhibits parathyroid-stimulated adenylate cyclase in iliac crest biopsies from uremic patients.
    Mortensen BM, Aarseth HP, Ganss R, Haug E, Gautvik KM, Gordeladze JO.
    Bone; 1993 Nov; 14(2):125-31. PubMed ID: 8334029
    [Abstract] [Full Text] [Related]

  • 4. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.
    Slatopolsky E, Weerts C, Thielan J, Horst R, Harter H, Martin KJ.
    J Clin Invest; 1984 Dec; 74(6):2136-43. PubMed ID: 6549016
    [Abstract] [Full Text] [Related]

  • 5. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V, Torregrosa V.
    Nefrologia; 2008 Dec; 28 Suppl 3():67-78. PubMed ID: 19018742
    [Abstract] [Full Text] [Related]

  • 6. Treatment of severe secondary hyperparathyroidism with administration of calcium carbonate, intermittent high oral doses of 1,25-dihydroxyvitamin D3 and dialysate with 3 mEq/1 calcium concentration.
    Perez-Mijares R, Gomez-Fernandez P, Almaraz-Jimenez M, Ramos-Diaz M, Rivero-Bohorquez J.
    Am J Nephrol; 1993 Dec; 13(2):149-54. PubMed ID: 8342582
    [Abstract] [Full Text] [Related]

  • 7. Alterations in serum and urine parameters reflecting bone turnover in uremic patients during treatment with 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3.
    Mortensen BM, Gordeladze JO, Lyngdal PT, Aarseth HP, Gautvik KM.
    Miner Electrolyte Metab; 1993 Dec; 19(2):78-85. PubMed ID: 8377728
    [Abstract] [Full Text] [Related]

  • 8. Effect of CAPD and hemodialysis on parathyroid function.
    Malberti F, Corradi B, Imbasciati E.
    Adv Perit Dial; 1996 Dec; 12():239-44. PubMed ID: 8865912
    [Abstract] [Full Text] [Related]

  • 9. Long-term effects of intermittent oral alphacalcidol, calcium carbonate and low-calcium dialysis (1.25 mmol L-1) on secondary hyperparathyroidism in patients on continuous ambulatory peritoneal dialysis.
    Brandi L, Nielsen PK, Bro S, Daugaard H, Olgaard K.
    J Intern Med; 1998 Aug; 244(2):121-31. PubMed ID: 10095798
    [Abstract] [Full Text] [Related]

  • 10. Effects of 24R,25-dihydroxyvitamin D3 in combination with 1 alpha-hydroxyvitamin D3 in predialysis renal insufficiency: biochemistry and histomorphometry of cancellous bone.
    Birkenhäger-Frenkel DH, Pols HA, Zeelenberg J, Eijgelsheim JJ, Schot R, Nigg AL, Weimar W, Mulder PG, Birkenhäger JC.
    J Bone Miner Res; 1995 Feb; 10(2):197-204. PubMed ID: 7754799
    [Abstract] [Full Text] [Related]

  • 11. Low- and high-turnover bone disease in continuous ambulatory peritoneal dialysis: effects of low-Ca2+ peritoneal dialysis solution.
    Carozzi S, Nasini MG, Santoni O, Pietrucci A.
    Perit Dial Int; 1993 Feb; 13 Suppl 2():S473-5. PubMed ID: 8399644
    [Abstract] [Full Text] [Related]

  • 12. The 'oral 1,25-dihydroxyvitamin D3 pulse therapy' in hemodialysis patients with severe secondary hyperparathyroidism.
    Tsukamoto Y, Nomura M, Takahashi Y, Takagi Y, Yoshida A, Nagaoka T, Togashi K, Kikawada R, Marumo F.
    Nephron; 1991 Feb; 57(1):23-8. PubMed ID: 2046811
    [Abstract] [Full Text] [Related]

  • 13. Control of parathyroid function in patients with a short history of hemodialysis.
    Nishi H, Sato T, Kurihara T, Kurosawa T, Fukagawa M.
    Ther Apher Dial; 2005 Feb; 9(1):39-43. PubMed ID: 15828904
    [Abstract] [Full Text] [Related]

  • 14. Comparisons between oral and intraperitoneal 1,25-dihydroxyvitamin D3 therapy in children treated with peritoneal dialysis.
    Jones CL, Vieth R, Spino M, Ledermann S, Kooh SW, Balfe J, Balfe JW.
    Clin Nephrol; 1994 Jul; 42(1):44-9. PubMed ID: 7923966
    [Abstract] [Full Text] [Related]

  • 15. Comparison between 1alpha(OH)D3 and 1,25(OH)2D3 on the suppression of plasma PTH levels in uremic patients, evaluated by the 'whole' and 'intact' PTH assays.
    Brandi L, Egfjord M, Olgaard K.
    Nephron Clin Pract; 2005 Jul; 99(4):c128-37. PubMed ID: 15722644
    [Abstract] [Full Text] [Related]

  • 16. Lack of relationship between parathyroid hormone and 1,25-dihydroxyvitamin D in chronic renal failure.
    Rudnicki M, McNair P, Transbøl I, Nielsen B.
    Nephron; 1991 Jul; 58(2):144-9. PubMed ID: 1865969
    [Abstract] [Full Text] [Related]

  • 17. Long-term effects of intravenous 1 alpha (OH)D3 combined with CaCO3 and low-calcium dialysis on secondary hyperparathyroidism and biochemical bone markers in patients on chronic hemodialysis.
    Brandi L, Daugaard H, Nielsen PK, Jensen LT, Egsmose C, Olgaard K.
    Nephron; 1996 Jul; 74(1):89-103. PubMed ID: 8883025
    [Abstract] [Full Text] [Related]

  • 18. Treatment of secondary hyperparathyroidism in hemodialyzed patients with high-dose calcium carbonate without vitamin D3 supplements.
    Teruel JL, Tenorio MT, Rodríguez JR, Marc n R, Orofino L, Rivera M, Ortuño J.
    Am J Nephrol; 1999 Jul; 19(3):428-32. PubMed ID: 10393383
    [Abstract] [Full Text] [Related]

  • 19. Enhancement of 24,25-dihydroxyvitamin D levels in patients treated with continuous ambulatory peritoneal dialysis.
    Shany S, Rapoport J, Zuili I, Yankowitz N, Chaimovitz C.
    Nephron; 1986 Jul; 42(2):141-5. PubMed ID: 3003603
    [Abstract] [Full Text] [Related]

  • 20. Effect of lanthanum carbonate on phosphate control in continuous ambulatory peritoneal dialysis patients in Korea: a randomized prospective study.
    Lee YK, Choi HY, Shin SK, Lee HY.
    Clin Nephrol; 2013 Feb; 79(2):136-42. PubMed ID: 23211335
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.